Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
60 participants
INTERVENTIONAL
2024-02-29
2028-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Stimulus magnitude
Differing levels of tactile stimulus will be applied
Tactile stimulation
Tactile stimuli of differing magnitudes will be applied
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tactile stimulation
Tactile stimuli of differing magnitudes will be applied
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
For Aim 1:
-age range of 18-23
For Aim 2:
* participants who are neurotypical will be a similar age to the participants with stroke
* participants who are neurotypical will have no musculoskeletal and neurological conditions
* participants with stroke will have a single stroke incident resulting in a unilateral lesion (ischemic and hemorrhagic)
* participants with stroke will be in the chronic phase (\>1 year from stroke onset)
* participants with stroke will have an onset of stroke after the age of 18
* participants with stroke who meet the criteria of having the capacity to provide informed consent, regardless of aphasia
Exclusion Criteria
* pregnant women
* prisoners
* adults not capable of consenting on their own behalf.
For Aim 2:
* participants with stroke who have used antispastic injections in the past six months
* participants with stroke who have a lesion in the brainstem and/or cerebellum
* participants with stroke who have a stroke arising due to brain surgery
* participants with stroke who have hemineglect
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Virginia Polytechnic Institute and State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Netta Gurari
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Netta Gurari, PhD
Role: PRINCIPAL_INVESTIGATOR
Virginia Polytechnic Institute and State University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Virginia Tech
Blacksburg, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Netta Gurari
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
23-1256
Identifier Type: -
Identifier Source: org_study_id